Inactive Instrument
DIAL BIORFD Stock Nasdaq Stockholm
Stocks
DIABIO BTA
SE0019173832
Biotechnology & Medical Research
| 1 day | +2.99% |
| Manager | Title | Age | Since |
|---|---|---|---|
Karin Wehlin
CEO | Chief Executive Officer | - | 23/11/2023 |
Fata Mrsic
DFI | Director of Finance/CFO | - | 14/06/2024 |
Emelie Danefur
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 41 | 01/01/2021 | |
| Chairman | 70 | 01/01/2021 | |
Kushagr Punyani
BRD | Director/Board Member | 35 | 01/01/2020 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.99% | +15.00% | - | - | 705K | |
| -4.63% | -7.57% | -3.17% | +10.69% | 48.5B | |
| +1.61% | -0.91% | +377.07% | +584.68% | 38.97B | |
| +2.61% | +3.96% | +9.16% | +61.36% | 35.43B | |
| -1.12% | -2.99% | +26.84% | -11.67% | 33.65B | |
| -0.58% | -0.69% | -0.56% | +30.30% | 26.58B | |
| +1.37% | -3.90% | - | - | 16.82B | |
| +0.71% | -0.84% | +72.13% | +116.76% | 15.18B | |
| -0.06% | +0.46% | +9.88% | +13.76% | 13.89B | |
| +0.26% | -0.80% | +19.33% | -32.25% | 12.76B | |
| Average | +0.32% | -0.93% | +63.83% | +96.70% | 26.87B | |
| Weighted average by Cap. | -0.36% | -1.00% | +76.60% | +121.98% |
Employees
4
